These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6808514

  • 1. Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.
    Kaltoft K, Nielsen LS, Zeuthen J, Danø K.
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3720-3. PubMed ID: 6808514
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.
    Nielsen LS, Hansen JG, Andreasen PA, Skriver L, Danø K, Zeuthen J.
    EMBO J; 1983 Jun; 2(1):115-9. PubMed ID: 11894897
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody.
    Danø K, Dabelsteen E, Nielsen LS, Kaltoft K, Wilson EL, Zeuthen J.
    J Histochem Cytochem; 1982 Nov; 30(11):1165-70. PubMed ID: 6183313
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS, Andreasen PA, Grøndahl-Hansen J, Huang JY, Kristensen P, Danø K.
    Thromb Haemost; 1986 Apr 30; 55(2):206-12. PubMed ID: 3520936
    [Abstract] [Full Text] [Related]

  • 5. Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.
    Stephens RW, Fordham CJ, Doe WF.
    Eur J Cancer Clin Oncol; 1987 Feb 30; 23(2):213-22. PubMed ID: 2965017
    [Abstract] [Full Text] [Related]

  • 6. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.
    Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoft K, Zeuthen J, Danø K.
    Biochemistry; 1982 Dec 07; 21(25):6410-5. PubMed ID: 6891264
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibody to human tissue plasminogen activator.
    Matsuo O, Tanbara Y, Okada K, Bando H, Nagoya T.
    Thromb Res; 1984 Dec 15; 36(6):517-26. PubMed ID: 6442014
    [Abstract] [Full Text] [Related]

  • 8. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M, Reich E.
    Biochem J; 1984 May 01; 219(3):971-8. PubMed ID: 6430276
    [Abstract] [Full Text] [Related]

  • 9. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa, Barshevskaia TN, Belogurov AA, Kratasiuk GA, Goriunova LE.
    Mol Biol (Mosk); 1986 May 01; 20(3):778-88. PubMed ID: 3088432
    [Abstract] [Full Text] [Related]

  • 10. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B, Lecander I, Brodin T, Lundblad A, Löw K.
    Thromb Haemost; 1985 Feb 18; 53(1):122-5. PubMed ID: 3922076
    [Abstract] [Full Text] [Related]

  • 11. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
    Nolli ML, Corti A, Soffientini A, Cassani G.
    Thromb Haemost; 1986 Oct 21; 56(2):214-8. PubMed ID: 2433787
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
    Sim PS, Fayle DR, Doe WF, Stephens RW.
    Eur J Biochem; 1986 Aug 01; 158(3):537-42. PubMed ID: 2942403
    [Abstract] [Full Text] [Related]

  • 13. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
    Schleef RR, Sinha M, Loskutoff DJ.
    Thromb Haemost; 1985 Apr 22; 53(2):170-5. PubMed ID: 4040658
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J, Kirchheimer JC, Turcu L, Christ G, Binder BR.
    Thromb Haemost; 1986 Jun 30; 55(3):347-51. PubMed ID: 3092391
    [Abstract] [Full Text] [Related]

  • 15. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW, Pawse AR.
    Indian J Biochem Biophys; 1991 Feb 30; 28(1):46-51. PubMed ID: 1905268
    [Abstract] [Full Text] [Related]

  • 16. Purification of plasminogen activators from human seminal plasma.
    Propping D, Zaneveld LJ, Tauber PF, Schumacher GF.
    Biochem J; 1978 May 01; 171(2):435-44. PubMed ID: 26336
    [Abstract] [Full Text] [Related]

  • 17. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS, Lipinski B, Greuwich V.
    Proc Natl Acad Sci U S A; 1981 Jul 01; 78(7):4265-9. PubMed ID: 6270665
    [Abstract] [Full Text] [Related]

  • 18. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
    Kirchheimer JC, Wojta J, Christ G, Binder BR.
    Proc Natl Acad Sci U S A; 1989 Jul 01; 86(14):5424-8. PubMed ID: 2501786
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
    Danø K, Nielsen LS, Møller V, Engelhart M.
    Biochim Biophys Acta; 1980 Jun 05; 630(1):146-51. PubMed ID: 6248125
    [Abstract] [Full Text] [Related]

  • 20. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
    Einarsson M, Brandt J, Kaplan L.
    Biochim Biophys Acta; 1985 Jul 18; 830(1):1-10. PubMed ID: 4040396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.